CA2239331C - Comprimes pharmaceutiques a base de cefuroxime axetil - Google Patents

Comprimes pharmaceutiques a base de cefuroxime axetil Download PDF

Info

Publication number
CA2239331C
CA2239331C CA 2239331 CA2239331A CA2239331C CA 2239331 C CA2239331 C CA 2239331C CA 2239331 CA2239331 CA 2239331 CA 2239331 A CA2239331 A CA 2239331A CA 2239331 C CA2239331 C CA 2239331C
Authority
CA
Canada
Prior art keywords
cefuroxime axetil
carbonate
tablet
bicarbonate
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2239331
Other languages
English (en)
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2239331 priority Critical patent/CA2239331C/fr
Priority to AU38074/99A priority patent/AU3807499A/en
Priority to PCT/CA1999/000446 priority patent/WO1999062559A1/fr
Application granted granted Critical
Publication of CA2239331C publication Critical patent/CA2239331C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2239331 1998-05-29 1998-05-29 Comprimes pharmaceutiques a base de cefuroxime axetil Expired - Fee Related CA2239331C (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA 2239331 CA2239331C (fr) 1998-05-29 1998-05-29 Comprimes pharmaceutiques a base de cefuroxime axetil
AU38074/99A AU3807499A (en) 1998-05-29 1999-05-18 Pharmaceutical tablets comprising cefuroxime axetil
PCT/CA1999/000446 WO1999062559A1 (fr) 1998-05-29 1999-05-18 Comprimes pharmaceutiques comprenant du cefuroxime axetil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2239331 CA2239331C (fr) 1998-05-29 1998-05-29 Comprimes pharmaceutiques a base de cefuroxime axetil

Publications (1)

Publication Number Publication Date
CA2239331C true CA2239331C (fr) 1999-11-30

Family

ID=4162505

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2239331 Expired - Fee Related CA2239331C (fr) 1998-05-29 1998-05-29 Comprimes pharmaceutiques a base de cefuroxime axetil

Country Status (3)

Country Link
AU (1) AU3807499A (fr)
CA (1) CA2239331C (fr)
WO (1) WO1999062559A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT413647B (de) 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
DK1342470T5 (da) * 2002-03-04 2008-04-07 Orbus Pharma Inc Cefuroxim-axetil-sammensætninger med hurtig frigivelse
WO2005002540A2 (fr) * 2003-07-01 2005-01-13 Ranbaxy Laboratories Limited Compositions de cefuroxime axetil sous forme de suspensions pharmaceutiques pulverulentes seches
KR100552567B1 (ko) * 2003-08-23 2006-02-15 한국유나이티드제약 주식회사 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법
GB0400971D0 (en) * 2004-01-16 2004-02-18 Sandoz Ag Pharmaceutical compositions
CN104230957B (zh) * 2013-06-09 2017-02-08 广东立国制药有限公司 头孢呋辛酸的制备方法及该过程中去除dcc内酯的方法
CN106109433A (zh) * 2016-08-10 2016-11-16 瑞阳制药有限公司 头孢呋辛酯薄膜衣片及其制备方法
CN114191375B (zh) * 2021-12-20 2022-07-26 广东金城金素制药有限公司 一种注射用头孢呋辛钠及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CA2209868C (fr) * 1997-08-15 2001-08-14 Bernard Charles Sherman Compositions pharmaceutiques a base de cefuroxime axetil

Also Published As

Publication number Publication date
WO1999062559A1 (fr) 1999-12-09
AU3807499A (en) 1999-12-20

Similar Documents

Publication Publication Date Title
US5064656A (en) Uncoated pharmaceutical reaction tablet
AU639137B2 (en) Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition
EP0250023B1 (fr) Forme de dosage de la nitrofurantoine
IE58951B1 (en) Solid pharmaceutical preparations for oral administration containing 9-deoxo-11-deoxy-9, 11-(IMINO(2-(2-methoxyethoxy)ethylidene)-oxy)-(9s)-erythromycin and processes for the preparation thereof
CA2000763C (fr) Produit dispersant
CA2182004C (fr) Comprimes enrobes de paracetamol et de domperidone
GB2105590A (en) Flotable controlled release preparations
CA2239331C (fr) Comprimes pharmaceutiques a base de cefuroxime axetil
AU2020213378A1 (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
US3865935A (en) Tableting of erythromycin base
EP1429748B1 (fr) Compositions solides comprenant du ramipril
JP2011525901A (ja) ロスバスタチンカルシウム含有医薬組成物
US5456925A (en) Pharmaceutical compositions containing furan derivatives
CA2408796C (fr) Procede servant a stabiliser une preparation
EP1684728B1 (fr) Forme non effervescente de naproxene de sodium comprenant du bicarbonate de soude
EP0121901B1 (fr) Pastilles à libération contrôlée indépendante du PH
US6485744B1 (en) Stabilized cefuroxime axetil
CA1108992A (fr) Composition pharmaceutique contenant du 1,3-bis(2- carboxychromone-5-yloxy)2-hydroxypropane
US5217965A (en) Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions
JP2006022040A (ja) 高い安定性を有するシンバスタチン固形製剤
RU2200558C1 (ru) Лекарственное средство, содержащее финастерид
CA2049817A1 (fr) Formulations de gemfibrozil
WO2003063867A1 (fr) Comprimes stables exempts de saccharides, comprenant un sel de quinapril ou de moexipril
MXPA96004298A (en) Solid dose forms containing bism

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed